Suppr超能文献

描述 RNA 聚合酶 I 单个核苷酸掺入的全局动力学机制揭示了 UMP 的快速掺入。

Global kinetic mechanism describing single nucleotide incorporation for RNA polymerase I reveals fast UMP incorporation.

机构信息

Department of Chemistry, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, AL 35294, USA.

出版信息

Biophys Chem. 2024 Sep;312:107281. doi: 10.1016/j.bpc.2024.107281. Epub 2024 Jun 8.

Abstract

RNA polymerase I (Pol I) is responsible for synthesizing ribosomal RNA, which is the rate limiting step in ribosome biogenesis. We have reported wide variability in the magnitude of the rate constants defining the rate limiting step in sequential nucleotide additions catalyzed by Pol I. in this study we sought to determine if base identity impacts the rate limiting step of nucleotide addition catalyzed by Pol I. To this end, we report a transient state kinetic interrogation of AMP, CMP, GMP, and UMP incorporations catalyzed by Pol I. We found that Pol I uses one kinetic mechanism to incorporate all nucleotides. However, we found that UMP incorporation is faster than AMP, CMP, and GMP additions. Further, we found that endonucleolytic removal of a dimer from the 3' end was fastest when the 3' terminal base is a UMP. It has been previously shown that both downstream and upstream template sequence identity impacts the kinetics of nucleotide addition. The results reported here show that the incoming base identity also impacts the magnitude of the observed rate limiting step.

摘要

RNA 聚合酶 I(Pol I)负责合成核糖体 RNA,这是核糖体生物发生中的限速步骤。我们已经报道了 Pol I 催化的连续核苷酸添加过程中限速步骤的速率常数的幅度存在广泛的可变性。在这项研究中,我们试图确定碱基身份是否会影响 Pol I 催化的核苷酸添加的限速步骤。为此,我们报告了对 Pol I 催化的 AMP、CMP、GMP 和 UMP 掺入的瞬态动力学研究。我们发现 Pol I 使用一种动力学机制来掺入所有核苷酸。然而,我们发现 UMP 的掺入速度比 AMP、CMP 和 GMP 的添加速度快。此外,我们发现当 3'末端碱基是 UMP 时,从 3'端内切切除二聚体最快。先前已经表明,下游和上游模板序列的身份都会影响核苷酸添加的动力学。这里报道的结果表明,进入碱基的身份也会影响观察到的限速步骤的幅度。

相似文献

4
Nicotine receptor partial agonists for smoking cessation.尼古丁受体部分激动剂用于戒烟。
Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.
6
Pathogen-reduced platelets for the prevention of bleeding.用于预防出血的去病原体血小板。
Cochrane Database Syst Rev. 2013 Mar 28(3):CD009072. doi: 10.1002/14651858.CD009072.pub2.
8
Uterine artery embolization for symptomatic uterine fibroids.子宫动脉栓塞术治疗有症状的子宫肌瘤。
Cochrane Database Syst Rev. 2014 Dec 26;2014(12):CD005073. doi: 10.1002/14651858.CD005073.pub4.

引用本文的文献

1
NTPs compete in the active site of RNA polymerases I and II.NTPs 在 RNA 聚合酶 I 和 II 的活性部位竞争。
Biophys Chem. 2024 Nov;314:107302. doi: 10.1016/j.bpc.2024.107302. Epub 2024 Aug 3.

本文引用的文献

9
Defining the divergent enzymatic properties of RNA polymerases I and II.定义 RNA 聚合酶 I 和 II 的酶学性质差异。
J Biol Chem. 2021 Jan-Jun;296:100051. doi: 10.1074/jbc.RA120.015904. Epub 2020 Nov 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验